Table 1.
Baseline characteristics of participants. Data are given as mean ± SEM (range)
| 17β-estradiol ≤20 pg/ml (n = 21) | 17β-estradiol > 40 pg/ml (n = 11) | |
|---|---|---|
| Age (years) | 52 ± 0.7 (45–56) | 51 ± 1.2 (45–53) |
| Menopause (months) | 20 ± 2.0 (6–36) | 13 ± 2.1 (6–24)* |
| Body weight (kg) | 74 ± 2.9 (52–96) | 73 ± 4.6 (64–113) |
| Body mass index (kg/m2) | 26 ± 0.9 (18–31) | 27 ± 1.4 (22–36) |
| Mean systolic blood pressure (mmHg) | 121 ± 3.3 (96–115) | 119 ± 4.9 (92–138) |
| Mean diastolic blood pressure (mmHg) | 74 ± 1.9 (60–91) | 73 ± 0.7 (52–92) |
| Total cholesterol (mg/dl) | 209 ± 5.0 (145–248) | 219 ± 16.5 (132–328) |
| Low density lipoprotein cholesterol (mg/dl) | 131 ± 6.8 (58–186) | 136 ± 13.7 (72–239) |
| High density lipoprotein cholesterol (mg/dl) | 60 ± 2.3 (49–83) | 61 ± 4.1 (42–84) |
| Triglycerides (mg/dl) | 83 ± 8.0 (39–176) | 84 ± 10.0 (49–153) |
| Blood glucose (mg/dl) | 92 ± 1.8 (79–115) | 88 ± 1.6 (75–94) |
| Follicle stimulating hormone (mIU/l) | 89 ± 7.6 (39–168) | 52 ± 5.8 (26–89)* |
| Estrogen (pg/ml) | ≤ 20 | 74 ± 12.8 (41–165) |
| Thyroid stimulating hormone (mIU/ml) | 1.8 ± 0.2 (0.5–4.4) | 2.7 ± 0.5 (0.8–5.8) |
| C-reactive protein (mg/l) | 1.9 ± 0.3 (0.2–5.8) | 2.1 ± 0.2 (0.4–2.8) |
*
Significantly different from low estrogen, p < 0.05